SARS-BLOCK

Unknown Manufacturer

Generate AI report

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

THERAPEUTIC AND DIAGNOSTIC VHH ANTIBODIES AGAINST SARS-COV-2 AND METHODS FOR THEIR ENHANCEMENT
EP 4188547 A1Applicant: MAX PLANCK GESELLSCHAFTPriority: 2020
EP
US
WO
6 publications
ANTI-SARS-COV-2 SPIKE GLYCOPROTEIN ANTIBODIES AND THE THERAPEUTIC USE THEREOF
EP 4284828 A1Applicant: TALEM THERAPEUTICS LLCPriority: 2021
EP
US
WO
6 publications
ANTI-SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS ANTIBODIES
EP 4251647 A1Applicant: BIO TECHNE CORPPriority: 2020
EP
US
WO
4 publications
NOVEL CORONAVIRUS TANDEM EPITOPE POLYPEPTIDE VACCINE AND USE THEREOF
US 2023338510 A1Applicant: SHANGHAI INST MATERIA MEDICA CASPriority: 2020
CN
US
WO
3 publications
PHARMACEUTICAL COMPOSITION FOR RESISTING INFECTION WITH SARS-COV-2 OR MUTANT THEREOF, AND COMBINED DRUG THEREOF
US 20260041761 A1Applicant: WESTVAC BIOPHARMA CO LTDPriority: 2022
EP
US
WO
3 publications
THERAPEUTIC INTERFERING PARTICLES FOR CORONA VIRUS
US 20250339508 A1Applicant: THE J DAVID GLADSTONE INST A TESTAMENTARY TRUST ESTABLISHED UNDER THE WILL OF J DAVID GLADPriority: 2020
CN
US
3 publications
ANTIVIRAL AGENTS FOR THE TREATMENT, CONTROL AND PREVENTION OF INFECTIONS BY CORONAVIRUSES
US 2006258577 A1Applicant: ERICKSON JOHN WPriority: 2004
US
3 publications
POLYPEPTIDE AND POLYPEPTIDE COMPOSITION SPECIFICALLY BINDING TO SARS-COV-2 SPIKE PROTEIN, AND PREPARATION METHOD AND USE THEREOF
US 20260234196 A1Applicant: INST BASIC MEDICAL SCIENCES CAMSPriority: 2021
US
WO
2 publications
Compositions that Block Activation of the Sars-CoV-2 Replication and Transcription Complex (RTC) and Methods of Use Thereof
US 2024301039 A1Applicant: NEW YORK UNIV IN ABU DHABI CORPORATIONPriority: 2021
US
WO
2 publications
PREPARATION AND USE OF MRNA VACCINE AND RECOMBINANT PROTEIN SUBUNIT VACCINE AGAINST SARS-COV-2 OR MUTANT
EP 4653011 A4Applicant: WESTVAC BIOPHARMA CO LTDPriority: 2023
EP
WO
2 publications

Drugs